Accelerated viraemia in cats vaccinated with fixed autologous FIV-infected cells

By Karlas J.A.   Siebelink K.H.J.   v. Peer M.A.   Huisman W.   Rimmelzwaan G.F.   D.M.E. Osterhaus A.  

Veterinary Immunology and Immunopathology, Vol. 65, Iss. 2, 1998-10 ,pp. : 353-365

Elsevier

Access to resources Recommend Favorite

Feline bone marrow transplantation: its use in FIV-infected cats

By Yamamoto J.K.   Pu R.   Arai M.   Pollock D.   Irausquin R.   Bova F.J.   Fox L.E.   Homer B.L.   Gengozian N.  

Veterinary Immunology and Immunopathology, Vol. 65, Iss. 2, 1998-10 ,pp. : 323-351

Elsevier

Access to resources Recommend Favorite

The use of human hematopoietic growth factors (rhGM-CSF and rhEPO) as a supportive therapy for FIV-infected cats

By Arai M.   Darmen J.   Lewis A.   Yamamoto J.K.  

Veterinary Immunology and Immunopathology, Vol. 77, Iss. 1, 2000-11 ,pp. : 71-92

Elsevier

Access to resources Recommend Favorite

Spontaneous programmed cell death (PCD) process of lymphocytes of FIV-infected cats: Cellular targets and modulation

By Guiot A.-L.   Rigal D.   Chappuis G.  

Veterinary Immunology and Immunopathology, Vol. 58, Iss. 2, 1997-09 ,pp. : 93-106

Elsevier

Access to resources Recommend Favorite

Evaluation of commercially available assays of neopterin and 2 -microglobulin for the assessment of disease progression in FIV-infected cats

By Beatty J.A.   Willett B.   Dalgleish A.   Jarrett O.  

Veterinary Immunology and Immunopathology, Vol. 56, Iss. 1, 1997-05 ,pp. : 185-189

Elsevier

Access to resources Recommend Favorite